rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Geraldine Pannu

Director

Company insider

Files Form 4 as: Director, Processa Pharmaceuticals; Director, RBB Bancorp.

In numbers

Trades disclosed
43
Buys
1
Sells
0
Bought
$11K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
5 Aug 2021
Last trade
26 Jul 2026
Last filed
28 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PCSA Processa PharmaceuticalsDirector · Biotechnology · last 26 Jul 20261 buy · 0 sells
RBB RBB BancorpDirector · Regional banks · last 21 May 20260 buys · 0 sells

Activity over time

1 Mar – 1 Oct
01Mar 26May 26Jul 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Jul 2026filed 28 Jul 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—33,500 at $0.00filing
26 Jul 2026filed 28 Jul 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—33,500 at $0.00filing
26 Jun 2026filed 30 Jun 2026PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code M—203filing
26 Jun 2026filed 30 Jun 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—203 at $0.00filing
26 Jun 2026filed 30 Jun 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—203 at $0.00filing
26 Jun 2026filed 30 Jun 2026PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code M—203filing
21 May 2026filed 26 May 2026RBB RBB BancorpRegional banksSEC FORM 4 Code M—700 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB BancorpRegional banksSEC FORM 4 Code M—1,846 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB Bancorpoption or derivative · Regional banksSEC FORM 4 Code M—700 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB Bancorpoption or derivative · Regional banksSEC FORM 4 Code M—700 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB Bancorpoption or derivative · Regional banksSEC FORM 4 Code A—2,546 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB Bancorpoption or derivative · Regional banksSEC FORM 4 Code M—1,846 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB Bancorpoption or derivative · Regional banksSEC FORM 4 Code A—2,546 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB Bancorpoption or derivative · Regional banksSEC FORM 4 Code M—1,846 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB BancorpRegional banksSEC FORM 4 Code M—700 at $0.00filing
21 May 2026filed 26 May 2026RBB RBB BancorpRegional banksSEC FORM 4 Code M—1,846 at $0.00filing
31 Mar 2026filed 1 Apr 2026PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Bought$5,2532,072 at $2.54filing
31 Mar 2026filed 1 Apr 2026PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Bought$5,2632,072 at $2.54filing
1 Oct 2025filed 3 Oct 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
1 Oct 2025filed 3 Oct 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—300,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Diana HansonChief Accounting Officer · Chief Accounting Officer at RBB Bancorp, filing Form 4 there in the last year
George K. NgChief Executive Officer · Chief Executive Officer at Processa Pharmaceuticals, filing Form 4 there in the last year
Sheila GujrathiDirector · Director at Processa Pharmaceuticals, filing Form 4 there in the last year
Patrick LinChief Business - Strategy Off · Chief Business - Strategy Off at Processa Pharmaceuticals, filing Form 4 there in the last year
Justin W. YorkeDirector · Director at Processa Pharmaceuticals, filing Form 4 there in the last year